Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care

Recruiting

• Conditions: Sarcoma

• Registration Number: NCT04300257
• Lead Sponsor: Kantonsspital Winterthur KSW

Brief Summary

The primary significance of this project is to perform a detailed analysis to assess the diagnostics, treatment and follow-up care, to develop a prediction model for future patient selection regarding various diagnostic and treatment procedures.

Detailed Description

Within the framework of interdisciplinary cooperation for a sarcoma problem, predictive and prognostic criteria will be developed that improve the treatment and particularly outcome.

The outcome variables include patient characteristics, tumor types and characteristics, histology, management and treatment strategies as well as recurrence rate and overall survival.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2019-10-19
• Study First Submitted: 2020-02-20
• Study First Submitted QC: 2020-03-05
• Study First Posted: 2020-03-09
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-19
• Last Update Posted: 2024-03-20
• Primary Completion: 2029-12-31
• Study Completion: 2029-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

• Malignant and intermediate and selected benign bone or soft tissue tumors, acc. to the WHO coding list of the SSN
• Female and male subjects of all ages

Read More

Exclusion Criteria

• Documented objection of subsequent use of personal health data

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Local recurrence,	5 years	s.o.
distant metastasis,	5 years	s.o.
biopsy taken by operating surgeon-radiologist-team,	5 years	s.o.
Surgery (yes/no),	5 years	s.o.
Surgical margin status,	5 years	s.o.
Diagnosis,	5 years	Data collected in the registry will be evaluated and analyzed to determine criteria to improve treatment strategies
pathology centrally reviewed,	5 years	s.o.
surgery performed by dedicated surgeon,	5 years	s.o.
Radiation Therapy (yes/no),	5 years	s.o.
Chemotherapy (yes/no),	5 years	s.o.
decision of board carried out,	5 years	s.o.
Status at last contact,	5 years	s.o.

Trial Locations

Locations (8)

Stadtspital Zürich Triemli; 🇨🇭 Zürich, Switzerland

Ente Ospedaliero Cantonale; 🇨🇭 Bellinzona, Tessin, Switzerland

Klinik Hirslanden; 🇨🇭 Zürich, Switzerland

Kantonsspital Graubünden; 🇨🇭 Chur, Graubünden, Switzerland

Kantonsspital Winterthur; 🇨🇭 Winterthur, Zuerich, Switzerland

SwissSarcomaNetwork; 🇨🇭 Winterthur, Zürich, Switzerland

Luzerner Kantonsspital; 🇨🇭 Lucerne, Switzerland

Pathologie Institut Enge; 🇨🇭 Zürich, Switzerland